174 related articles for article (PubMed ID: 12069988)
1. Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.
Ortoneda M; Capilla J; Pastor FJ; Pujol I; Guarro J
Antimicrob Agents Chemother; 2002 Jul; 46(7):2273-5. PubMed ID: 12069988
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J
Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antifungal treatments for murine fusariosis.
Spellberg B; Schwartz J; Fu Y; Avanesian V; Adler-Moore J; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2006 Nov; 58(5):973-9. PubMed ID: 16973654
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
5. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
J Antimicrob Chemother; 2009 Feb; 63(2):361-4. PubMed ID: 19054804
[TBL] [Abstract][Full Text] [Related]
6. Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2004 Jun; 48(6):2140-3. PubMed ID: 15155212
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B therapy of murine histoplasmosis.
Graybill JR; Bocanegra R
Antimicrob Agents Chemother; 1995 Aug; 39(8):1885-7. PubMed ID: 7486941
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a murine model of systemic candidiasis with liposomal amphotericin B bearing antibody to Candida albicans.
Hospenthal D; Gretzinger K; Rogers A
J Med Microbiol; 1989 Nov; 30(3):193-7. PubMed ID: 2685314
[TBL] [Abstract][Full Text] [Related]
10. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B.
Eljaschewitsch J; Sandfort J; Tintelnot K; Horbach I; Ruf B
Mycoses; 1996; 39(3-4):115-9. PubMed ID: 8767004
[TBL] [Abstract][Full Text] [Related]
11. Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Ruíz-Cendoya M; Mariné M; Rodríguez MM; Guarro J
Antimicrob Agents Chemother; 2009 Apr; 53(4):1705-8. PubMed ID: 19188382
[TBL] [Abstract][Full Text] [Related]
12. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex.
Engelhard D; Eldor A; Polacheck I; Hardan I; Ben-Yehuda D; Amselem S; Salkin IF; Lopez-Berestein G; Sacks T; Rachmilewitz EA
Leuk Lymphoma; 1993 Mar; 9(4-5):385-92. PubMed ID: 8348074
[TBL] [Abstract][Full Text] [Related]
13. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of resistant Fusarium solani keratitis with liposomal amphotericin B].
Touvron G; Denis D; Doat M; Girard A; Brandely ML; Chast F; Renard G
J Fr Ophtalmol; 2009 Dec; 32(10):721-6. PubMed ID: 19942316
[TBL] [Abstract][Full Text] [Related]
15. Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii.
Batista-Duharte A; Lastre M; Romeu B; Portuondo DL; Téllez-Martínez D; Manente FA; Pérez O; Carlos IZ
Int Immunopharmacol; 2016 Nov; 40():277-287. PubMed ID: 27639705
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Ruíz-Cendoya M; Pastor J; Guarro J
Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
Ortoneda M; Capilla J; Pujol I; Pastor FJ; Mayayo E; Fernández-Ballart J; Guarro J
J Antimicrob Chemother; 2002 Mar; 49(3):525-9. PubMed ID: 11864953
[TBL] [Abstract][Full Text] [Related]
18. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
Rieger CT; Dittmer M; Ostermann H
Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
[TBL] [Abstract][Full Text] [Related]
19. The use of lipid formulations of amphotericin B for systemic fungal infections.
Leenders AC; de Marie S
Leukemia; 1996 Oct; 10(10):1570-5. PubMed ID: 8847891
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Rodríguez MM; Pastor FJ; Serena C; Guarro J
Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
